Markets Bet on Peace | Buffett Buys the Bottom | Novartis Joins the RNA Race

Easing tensions, bold bets, and biotech breakthroughs ... from Trump-Xi diplomacy to Buffett’s industrial revival and Novartis’s $12 B pivot into RNA, the market’s mood has turned from fear to foresight.